OxBioDynamics's profile picture. OBD is a global biotech company advancing personalized healthcare by developing and commercializing #PrecisionMedicine tests for life-changing diseases.

Oxford BioDynamics

@OxBioDynamics

OBD is a global biotech company advancing personalized healthcare by developing and commercializing #PrecisionMedicine tests for life-changing diseases.

Oxford BioDynamics reposted

🚨 Breakthrough in #MECFS research! Join our free webinar “From Mystery to Measurable: The Science Behind the New ME/CFS Blood Test” 🧬Learn how a 96% accurate test could transform diagnosis + treatment. 🗓️ Jan 15, 2026 | 9–10 am PT / 12- 1 pm ET. 🔗ow.ly/aZk450XiOeU

PlzSolveCFS's tweet image. 🚨 Breakthrough in #MECFS research! Join our free webinar “From Mystery to Measurable: The Science Behind the New ME/CFS Blood Test” 
🧬Learn how a 96% accurate test could transform diagnosis + treatment. 
🗓️ Jan 15, 2026 | 9–10 am PT / 12- 1 pm ET.
🔗ow.ly/aZk450XiOeU

Oxford BioDynamics reposted

🏅Proud to see our publication in Cancers recognized as a “Highly Viewed Paper” by #MDPI. The meta-analysis highlights our #EpiSwitchPSE blood test as a compelling tool for early accurate #prostatecancer detection to address urgent global need. #OBD @OxBioDynamics @MDPIOpenAccess

📢 Check out the "Highly Viewed Papers and Hot Topic Special Issues on Cancer Causes, Screening and Diagnosis" 🤗 Find more details here: mdpi.com/journal/cancer… #CancersMDPI #OpenAccess 🔓 #HighlyViewed #SpecialIssue #Causes #Screening #Diagnosis

Cancers_MDPI's tweet image. 📢 Check out the "Highly Viewed Papers and Hot Topic Special Issues on Cancer Causes, Screening and Diagnosis"
🤗 Find more details here: mdpi.com/journal/cancer…

#CancersMDPI #OpenAccess 🔓 #HighlyViewed #SpecialIssue #Causes #Screening #Diagnosis


We are pleased to announce this morning that the company #OBD has raised £7 million from existing and new investors, subject to shareholder approval. Read more here: obdx.co/238a49

OxBioDynamics's tweet image. We are pleased to announce this morning that the company #OBD has raised £7 million from existing and new investors, subject to shareholder approval. Read more here: obdx.co/238a49

Another look at our breakthrough data published last week in the peer-reviewed Journal of Translational Medicine with the @uniofeastanglia. A simple, accurate #bloodtest could transform #ChronicFatigue Syndrome (ME/CFS) for millions. #OBD #MECFS @BioMedCentral


Oxford BioDynamics reposted

A privilege to join @PCR_News at @HouseofCommons. Rt Hon MPs @DavidLammy & @RishiSunak showed united support for equitable #ProstateCancer #screening. @OxBioDynamics' #EpiSwitchPSE was highlighted in the report as a tool to enable practical wide #NHS testing. @94percent_com #OBD

DrBartu's tweet image. A privilege to join @PCR_News at @HouseofCommons. Rt Hon MPs @DavidLammy & @RishiSunak showed united support for equitable #ProstateCancer #screening. @OxBioDynamics' #EpiSwitchPSE was highlighted in the report as a tool to enable practical wide #NHS testing. @94percent_com #OBD
DrBartu's tweet image. A privilege to join @PCR_News at @HouseofCommons. Rt Hon MPs @DavidLammy & @RishiSunak showed united support for equitable #ProstateCancer #screening. @OxBioDynamics' #EpiSwitchPSE was highlighted in the report as a tool to enable practical wide #NHS testing. @94percent_com #OBD
DrBartu's tweet image. A privilege to join @PCR_News at @HouseofCommons. Rt Hon MPs @DavidLammy & @RishiSunak showed united support for equitable #ProstateCancer #screening. @OxBioDynamics' #EpiSwitchPSE was highlighted in the report as a tool to enable practical wide #NHS testing. @94percent_com #OBD
DrBartu's tweet image. A privilege to join @PCR_News at @HouseofCommons. Rt Hon MPs @DavidLammy & @RishiSunak showed united support for equitable #ProstateCancer #screening. @OxBioDynamics' #EpiSwitchPSE was highlighted in the report as a tool to enable practical wide #NHS testing. @94percent_com #OBD

The Prostate Cancer Research report launching today shows @NHSuk #prostatecancer screening is feasible, and helped with an accurate reflex test like #EpiSwitchPSE—cutting anticipated burden on MRI by >86% and biopsy by >84%. @PCR_News @94percent_com #OBD #ProactiveForYourProstate

We’re delighted to be hosting an event at the House of Commons today to launch our report ‘Prostate Cancer Screening: The Impact on the NHS. Learn more at: prostate-cancer-research.org.uk/screening-repo…

PCR_News's tweet image. We’re delighted to be hosting an event at the House of Commons today to launch our report ‘Prostate Cancer Screening: The Impact on the NHS.

Learn more at: prostate-cancer-research.org.uk/screening-repo…


Oxford BioDynamics reposted

Oxford BioDynamics' Bartu Ahiska on breakthrough CFS test @OxBioDynamics proactiveinvestors.com/companies/news… #Health #Biotech


Yesterday, major media—@thetimes @guardian @Telegraph @DailyMirror @SkyNews @itvnews & more—spotlighted the breakthrough #ChronicFatigue syndrome blood test by @OxBioDynamics & @uniofeastanglia. 📖 Read more: obdx.co/nw8 #OBD #EpiSwitch #MECFS #MillionsMissing

OxBioDynamics's tweet image. Yesterday, major media—@thetimes @guardian @Telegraph @DailyMirror @SkyNews @itvnews & more—spotlighted the breakthrough #ChronicFatigue syndrome blood test by @OxBioDynamics & @uniofeastanglia.
📖 Read more: obdx.co/nw8
#OBD #EpiSwitch #MECFS #MillionsMissing

@OxBioDynamics (#OBD) and @uniofeastanglia unveil a breakthrough first-in-class #bloodtest for #ChronicFatigueSyndrome (#CFS/ME), with high 96% accuracy. ✅Peer-reviewed in Journal of Transl Med ✅Hope for millions who face delays & misdiagnosis Read more: obdx.co/cfs

OxBioDynamics's tweet image. @OxBioDynamics (#OBD) and @uniofeastanglia unveil a breakthrough first-in-class #bloodtest for #ChronicFatigueSyndrome (#CFS/ME), with high 96% accuracy.
✅Peer-reviewed in Journal of Transl Med
✅Hope for millions who face delays & misdiagnosis
Read more: obdx.co/cfs

Oxford BioDynamics reposted

June was Men’s Health Month— #ProstateCancer is the UK’s most common male cancer. Advocate Alfred Samuels shares his powerful story & calls for a national #NHS screening program. 👉Learn more about Alfred’s story: mypse.co/9d7 #MensHealthMonth #ProstateCancerAwareness

94percent_com's tweet image. June was Men’s Health Month—
#ProstateCancer is the UK’s most common male cancer. Advocate Alfred Samuels shares his powerful story & calls for a national #NHS screening program.
👉Learn more about Alfred’s story: mypse.co/9d7
#MensHealthMonth #ProstateCancerAwareness

Oxford BioDynamics reposted

📢 Michael Land will represent @OxBioDynamics at the 65th Southern Society of Urological Surgeons Annual Conference #SSUS25, 5-7 Oct at The Ritz-Carlton Dallas @RClascolinas, Irving TX. Learn about #EpiSwitchPSE for detecting #ProstateCancer with 94% accuracy. #SSUS #urology #OBD

94percent_com's tweet image. 📢 Michael Land will represent @OxBioDynamics at the 65th Southern Society of Urological Surgeons Annual Conference #SSUS25, 5-7 Oct at The Ritz-Carlton Dallas @RClascolinas, Irving TX. Learn about #EpiSwitchPSE for detecting #ProstateCancer with 94% accuracy. #SSUS #urology #OBD

Oxford BioDynamics reposted

Great to see us featured in @TheOxfordMail. This #ProstateCancerAwarenessMonth, we welcomed @AnnelieseDodds MP to Oxford BioDynamics (#OBD), where she saw our #Oxford lab delivering the advanced #EpiSwitchPSE #prostatecancer blood test. Read the coverage 👉mypse.co/oxm


Oxford BioDynamics reposted

🩺The Maxwell Practice, private #GP in Henley-on-Thames, now provides #ProstateCancer testing with the #EpiSwitchPSE blood test by @OxBioDynamics. 🔗Learn about The Maxwell Practice #prostatescreening services: themaxwellpractice.com/prostate-cance… #OBD #PSE #PCAM #MensHealth @94percent_com

94percent_com's tweet image. 🩺The Maxwell Practice, private #GP in Henley-on-Thames, now provides #ProstateCancer testing with the #EpiSwitchPSE blood test by @OxBioDynamics.

🔗Learn about The Maxwell Practice #prostatescreening services: themaxwellpractice.com/prostate-cance…

#OBD #PSE #PCAM #MensHealth @94percent_com

Oxford BioDynamics reposted

📊 1 in 8 men face #prostatecancer in their life. Early stages often show no symptoms, making testing vital. At #OBD, we’re committed to helping you #GetChecked with the #EpiSwitchPSE test. Learn about action to take this #ProstateCancerAwareness Month at: ZEROcancer.org/September

September is Prostate Cancer Awareness Month, and at ZERO Prostate Cancer, we know awareness is not enough. We need action. The reality is urgent: Every 15 minutes in the U.S., a man dies from prostate cancer. It often has no symptoms and strikes men in their 40s and 50s, not…



Thank you @AnnelieseDodds for visiting Oxford BioDynamics (#OBD) at @ARCOxford_io to see our clinical lab in action, delivering the #EpiSwitchPSE—our leading #prostatecancer detection blood test. We're proud to be part of #Oxford’s innovation ecosystem! @94percent_com

It was great to spend time at Oxford BioDynamics, an excellent example of the world-leading innovation happening here in Oxford East. The work they do in Cowley has the potential to transform cancer diagnostics around the world and ensure that people get the treatments they need

AnnelieseDodds's tweet image. It was great to spend time at Oxford BioDynamics, an excellent example of the world-leading innovation happening here in Oxford East.  The work they do in Cowley has the potential to transform cancer diagnostics around the world and ensure that people get the treatments they need


Oxford BioDynamics reposted

🔎Another look at the publication of results from our #PROWES trial. A major milestone supporting #EpiSwitchCiRT’s role in guiding #cancer #immunotherapy, and validating its real-world impact on clinical decision-making: 🔗mycirt.co/p25 #Oncology #OBD @OxBioDynamics

EpiSwitchCiRT's tweet image. 🔎Another look at the publication of results from our #PROWES trial. A major milestone supporting #EpiSwitchCiRT’s role in guiding #cancer #immunotherapy, and validating its real-world impact on clinical decision-making: 🔗mycirt.co/p25
#Oncology #OBD @OxBioDynamics

Oxford BioDynamics reposted

Grateful to Dr Kashyap Patel for leading the #EpiSwitchCiRT study, prioritising better patient #immunotherapy outcomes. His work shows how community oncologists can turn innovation into improved care. Thanks @oncodaily for sharing this perspective. 🔗mycirt.co/ond #OBD


Oxford BioDynamics reposted

To improve early #ProstateCancer diagnosis and outcomes, Imperial College Healthcare Private Care now offers the #EpiSwitchPSE test by @OxBioDynamics. 🔗Learn about the prostate #cancer pathway at Thames View, Charing Cross Hospital: mypse.co/cch #PCAM #urology #OBD

94percent_com's tweet image. To improve early #ProstateCancer diagnosis and outcomes, Imperial College Healthcare Private Care now offers the #EpiSwitchPSE test by @OxBioDynamics.

🔗Learn about the prostate #cancer pathway at Thames View, Charing Cross Hospital: mypse.co/cch

#PCAM #urology #OBD

Oxford BioDynamics reposted

313,000+ men will be diagnosed with #ProstateCancer in 2025. Urologist Dr. Garrett Pohlman (@gpohlmanmd) shares new tools for earlier, more accurate detection: mypse.co/dgp @OxBioDynamics #MensHealth #Urology #PCAM #OBD #EpiSwitchPSE

94percent_com's tweet image. 313,000+ men will be diagnosed with #ProstateCancer in 2025. Urologist Dr. Garrett Pohlman (@gpohlmanmd) shares new tools for earlier, more accurate detection: mypse.co/dgp

@OxBioDynamics #MensHealth #Urology #PCAM #OBD #EpiSwitchPSE

Loading...

Something went wrong.


Something went wrong.